Description | Neurotrophinsaregrowthfactorsthatregulateneuronaldevelopment,maintenanceandplasticity.Thesehomo-dimericproteinsactivateamultitudeofintracellularsignallingcascadesthroughtheirinteractionwithTrkreceptorsandp75NTR. TheNeurotrophinAntibodyKit(TrialSize)containsacollectionofBiosensispopularsheepantibodiesraisedagainstBDNF(S-015-500),NGF(S-052-500),NT3(S-057-500)andNT4/5(S-059-500).ThekitiscompletedwithonevialofnormalsheepIgG(S-1754-100)foruseasnegativecontrol.ThisfullsizeversionofBiosensisNeurotrophinAntibodyKitcontains500μgsheepIgGofeachantibody. Thiskitpresentsacost-effectivewaytoinvestigateneurotrophinproteinexpressionandfunctionbyimmunologicaltechniquessuchasimmunohistochemistry,ELISA,andinhibitionofBIOLOGicalactivity. |
Relatedproducts | S-015-500,SheeppolyclonalantibodytorhBDNF S-052-500,SheeppolyclonalantibodytobetaNGF S-057-500,SheeppolyclonalantibodytorhNT3 S-059-500,SheeppolyclonalantibodytorhNT4/5 S-1754-500,NormalsheepIgGfromnon-immunizedanimal |
BatchNo. | Seeproductlabel. |
Unitsize | 5vials,eachcontaining500μgsheepIgG |
Antigen | BDNF:recombinanthumanBDNF NGF:nativemousebetaNGFpurifiedfromsuBMAxillarysalivarygland(95%puritybyPAGE) NT3:recombinanthumanNT3 NT4/5:recombinanthumanNT4 |
AntibodyType | Polyclonal. |
Isotype | IgG |
Accession | P23560BDNF_HUMAN; P01139NGF_MOUSE; P20783NTF3_HUMAN; P34130NTF4_HUMAN; |
Producedin | Sheep. |
Purity | ProteinGpurifiedIgG. |
Applications | Immunohistochemistry:1-10µg/mL.BDNFantibodyworksbestonZamboni"sfixed,frozentissue,andisnotrecommendedforparaffin-embeddedtissue. ELISA:1-10µg/mL. WesternBlotting:1-10µg/mL.WesternblottingisnotrecommendedfortheBDNFantibody. Inhibitionofbiologicalactivityinvitro/invivo:ExpectedED50(invivo)valuesareintherangeof2-10µg/mL.TheNGFantibodycompletelyinhibitsneuronalsurvivalandtheoutgrowthactionsofmurineNGFinchickenDRGinvitro. Biosensisrecommendsoptimaldilutions/concentrationsshouldbedeterminedbytheenduser.Thenegativecontrol(normalsheepIgG)shouldbeusedatthesameconcentrationastheneurotrophinantibodies. |
Specificity | BDNFAntibody:Across-reactivityoflessthan1%againstmouseNGF,recombinanthumanNT3orNT4/5hasbeenshownbyELISA. NGFAntibody:Across-reactivityoflessthan1%againstrecombinanthumanBDNF,NT3andNT4/5byELISAhasbeenshown. NT3Antibody:Across-reactivityoflessthan1%tomouseNGF,recombinanthumanBDNFand5%toNT4/5hasbeenshownbyELISA. NT4/5Antibody:Lessthan1%cross-reactivityagainstNGF,recombinanthumanBDNFand5%toNT3hasbeenshownbydotblot. |
SpeciesAgainst | Human(BDNF,NT3andNT4/5). Mouse(NGF). |
Cross-reactivity | Neurotrophinssharealargedegreeofhomologyamonghuman,rodentandothermammalianspecies,thustheseneurotrophinantibodiesareusefulforanumberofspecies,includinghuman,mouseandrat. |
Form | LyophilizedfromPBS,pH7.4,withoutpreservatives. |
Appearance | Whitepowder. |
Reconstitution | Reconstituteeachvialwith500µLsterile-filtered,ultrapurewater,toachieveanantibodyconcentrationof1mg/mL.Centrifugebrieflytoremoveanyinsolublematerial. |
Storage | Storelyophilised,unopenedvialsat2-8°Corlower.Afterreconstitution,preparealiquotsandstoreat-20°CforahigherstABIlity.Avoidfreeze-thawcycles. |
ExpiryDate | 12monthsafterpurchase(unopenedvials). |
Biosensis专注于神经科学领域的抗体和试剂的开发,特别是神经营养因子和神经营养因子受体。 近30年来,Biosensis一直是该领域的全球领航者和OEM供应商。除神经营养因子,我们的神经科学产品组合还被广泛用于神经退行性疾病、神经发育和神经代谢的研究。重点研究领域包括阿尔茨海默氏症(AD)、帕金森氏症(PD)和肌萎缩侧索硬化(ALS)疾病,以及自噬和代谢应激障碍,包括肥胖、代谢综合征的研究、神经免疫学和炎症。